Visalytics
Visalytics
approved EB-2 (NIW)

PhD Student

Pharmaceutical Bioscience · Iran · 2025-09-08

Processing Time
598 days
Decision Date
2025-09-08
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to advance drug discovery by designing and improving in-vitro testing methodologies to enhance precision and streamline timelines in pre-clinical research. Her work focuses on creating standardized approaches for toxin assessment to reduce the reliance on animal testing and lower the high failure rates of clinical trials.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses the high cost and failure rate of drug development, which is of critical importance to the healthcare industry.

2 Well-positioned to Advance the Endeavor Met

The petitioner's publication record, patent application, and funding from major foundations demonstrate her capability to lead this research.

3 Balance of Interests Met

The potential for more efficient drug discovery and reduced animal testing makes it beneficial for the U.S. to waive the labor certification.

Why This Petition Was Approved

The petition was approved based on the petitioner's record of six peer-reviewed journal articles, 47 citations, and a co-authored patent application. Her work received significant funding from the Swedish Research Council, the Swedish Brain Foundation, and the Novo Nordisk Foundation, demonstrating international recognition. The case successfully satisfied all three Dhanasar prongs through evidence of her research impact and professional peer review contributions.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Patents
Grants
Conference Presentations
Judging Experience
Original Contributions
Reference Letters Dependent

Similar Cases

Others

Pharmaceuticals · South Korea

WeGreened EB-2 (NIW) approved
54 days 2025-03-24
The petitioner proposes to continue her research in pharmaceutical science by integrating advanced technologies and computational approaches to develop novel drug candidates. Her work focuses on improving drug delivery systems to create more effective, affordable, and stable medications for chronic diseases including cancer, diabetes, hypertension, and neurodegenerative diseases.
View Case

Scientist

Pharmaceuticals · India

WeGreened EB-2 (NIW) approved
Wisconsin 94 days 2025-01-29
The petitioner proposes to investigate the design, synthesis, optimization, and characterization of small molecule compounds. This work focuses on developing therapeutic agents to address drug-resistant infections and improve medication safety and efficacy.
View Case

Clinical Researcher

Biotechnology

WeGreened EB-2 (NIW) approved
602 days 2025-09-18
The petitioner proposes to develop innovative clinical trial methodologies to evaluate new treatments, vaccines, and medical devices. This work focuses on optimizing health outcomes and improving patient diagnosis through efficient testing of emerging medical technologies.
View Case

Chemist

Pharmaceuticals · India

WeGreened EB-2 (NIW) approved
New Jersey 47 days 2025-07-30
The petitioner proposes to apply pharmaceutical science methodologies to streamline drug development and ensure regulatory compliance. Her work focuses on formulation development, analytical validation, and regulatory strategy improvement to reduce the time and cost of bringing drug compounds from the lab to the market.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Pharmaceuticals cases More cases from Iran

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-09-08.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 598 days
Criteria Met 3 / 3
Evidence Types 8

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Iran All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist